SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-071432
Filing Date
2020-06-09
Accepted
2020-06-09 16:40:41
Documents
12
Period of Report
2020-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022177d1_8k.htm   iXBRL 8-K 32739
  Complete submission text file 0001104659-20-071432.txt   207850

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vygr-20200604.xsd EX-101.SCH 3219
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20200604_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20200604_pre.xml EX-101.PRE 22732
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2022177d1_8k_htm.xml XML 3617
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 20952429
SIC: 2836 Biological Products, (No Diagnostic Substances)